Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

NCT01732068 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
51
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Universitair Ziekenhuis Brussel